prazosin has been researched along with Weight Loss in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Morphine tolerance was induced using a 3-day cumulative twice-daily dosing regimen with s." | 1.32 | Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice. ( Lähdesmäki, J; Ozdoğan, UK; Scheinin, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozdoğan, UK | 1 |
| Lähdesmäki, J | 1 |
| Scheinin, M | 1 |
1 other study available for prazosin and Weight Loss
| Article | Year |
|---|---|
Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Animals; Behavior, Anim | 2003 |